150 related articles for article (PubMed ID: 1528133)
1. Endometrial effects of transdermal estradiol/norethisterone acetate.
Lindgren R; Risberg B; Hammar M; Berg G; Pryse-Davies J
Maturitas; 1992 Aug; 15(1):71-8. PubMed ID: 1528133
[TBL] [Abstract][Full Text] [Related]
2. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
[TBL] [Abstract][Full Text] [Related]
3. Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women.
Brynhildsen J; Hammar M
Menopause; 2002; 9(2):137-44. PubMed ID: 11875333
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
[TBL] [Abstract][Full Text] [Related]
5. Does low-dose, transdermal, norethisterone acetate reliably cause endometrial transformation in postmenopausal oestrogen-users?
Fraser D; Whitehead M; Schenkel L; Pryse-Davies J
Maturitas; 1993 Jan; 16(1):23-30. PubMed ID: 8429801
[TBL] [Abstract][Full Text] [Related]
6. Transdermal hormonal replacement therapy with transdermal progestin every second month.
Lindgren R; Risberg B; Hammar M; Berg G
Maturitas; 1995 Jun; 22(1):25-30. PubMed ID: 7666813
[TBL] [Abstract][Full Text] [Related]
7. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Johannisson E; Holinka CF; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
[TBL] [Abstract][Full Text] [Related]
8. Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.
Samsioe G; Boschitsch E; Concin H; De Geyter C; Ehrenborg A; Heikkinen J; Hobson R; Arguinzoniz M; Ibarra de Palacios P; Scheurer C; Schmidt G;
Climacteric; 2006 Oct; 9(5):368-79. PubMed ID: 17080587
[TBL] [Abstract][Full Text] [Related]
9. A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group.
Archer DF; Furst K; Tipping D; Dain MP; Vandepol C
Obstet Gynecol; 1999 Oct; 94(4):498-503. PubMed ID: 10511348
[TBL] [Abstract][Full Text] [Related]
10. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
[TBL] [Abstract][Full Text] [Related]
11. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
[TBL] [Abstract][Full Text] [Related]
12. Plasma lipid and lipoprotein effects of transdermal administration of estradiol and estradiol/norethisterone acetate.
Lindgren R; Berg G; Hammar M; Larsson-Cohn U; Olsson AG
Eur J Obstet Gynecol Reprod Biol; 1992 Dec; 47(3):213-21. PubMed ID: 1294408
[TBL] [Abstract][Full Text] [Related]
13. A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women.
Koninckx PR; Spielmann D
Gynecol Endocrinol; 2005 Aug; 21(2):82-9. PubMed ID: 16294460
[TBL] [Abstract][Full Text] [Related]
14. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
15. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
16. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
Boerrigter PJ; van de Weijer PH; Baak JP; Fox H; Haspels AA; Kenemans P
Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
[TBL] [Abstract][Full Text] [Related]
17. Endometrial responses to transdermal estradiol in postmenopausal women.
Whitehead MI; Padwick ML; Endacott J; Pryse-Davies J
Am J Obstet Gynecol; 1985 Aug; 152(8):1079-84. PubMed ID: 4025456
[TBL] [Abstract][Full Text] [Related]
18. Sequential combined transdermal and oral postmenopausal hormone replacement therapies: effects on bleeding patterns and endometrial histology.
Sendag F; Terek MC; Karadadas N
Arch Gynecol Obstet; 2001 Nov; 265(4):209-13. PubMed ID: 11789748
[TBL] [Abstract][Full Text] [Related]
19. Transdermal administration of oestrogen/progestagen hormone replacement therapy.
Whitehead MI; Fraser D; Schenkel L; Crook D; Stevenson JC
Lancet; 1990 Feb; 335(8685):310-2. PubMed ID: 1967769
[TBL] [Abstract][Full Text] [Related]
20. A transdermal regimen for continuous combined hormone replacement therapy in the menopause.
Keller PJ; Hotz E; Imthurn B
Maturitas; 1992 Dec; 15(3):195-8. PubMed ID: 1465033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]